HEADER HYDROLASE/INHIBITOR 08-JAN-17 5UGG TITLE PROTEASE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLASMINOGEN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 562-810; COMPND 5 SYNONYM: MICROPLASMIN; COMPND 6 EC: 3.4.21.7; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: MICROPLASMIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PLG; SOURCE 6 EXPRESSION_SYSTEM: KOMAGATAELLA PHAFFII GS115; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 644223 KEYWDS FIBRINOLYSIS, YO, PLASMIN, INHIBITOR, HYDROLASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.H.P.LAW,G.WU,J.C.WHISSTOCK REVDAT 4 08-JAN-20 5UGG 1 REMARK REVDAT 3 17-JAN-18 5UGG 1 JRNL REVDAT 2 27-SEP-17 5UGG 1 REMARK REVDAT 1 31-MAY-17 5UGG 0 JRNL AUTH R.H.P.LAW,G.WU,E.W.W.LEUNG,K.HIDAKA,A.J.QUEK, JRNL AUTH 2 T.T.CARADOC-DAVIES,D.JEEVARAJAH,P.J.CONROY,N.M.KIRBY, JRNL AUTH 3 R.S.NORTON,Y.TSUDA,J.C.WHISSTOCK JRNL TITL X-RAY CRYSTAL STRUCTURE OF PLASMIN WITH TRANEXAMIC JRNL TITL 2 ACID-DERIVED ACTIVE SITE INHIBITORS. JRNL REF BLOOD ADV V. 1 766 2017 JRNL REFN ISSN 2473-9529 JRNL PMID 29296720 JRNL DOI 10.1182/BLOODADVANCES.2016004150 REMARK 2 REMARK 2 RESOLUTION. 1.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.57 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 3 NUMBER OF REFLECTIONS : 67974 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.165 REMARK 3 R VALUE (WORKING SET) : 0.164 REMARK 3 FREE R VALUE : 0.176 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.940 REMARK 3 FREE R VALUE TEST SET COUNT : 3358 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.20 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.23 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 75.49 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3856 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1690 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3656 REMARK 3 BIN R VALUE (WORKING SET) : 0.1680 REMARK 3 BIN FREE R VALUE : 0.1860 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.19 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 200 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1893 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 289 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 9.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.55 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.03580 REMARK 3 B22 (A**2) : 0.46660 REMARK 3 B33 (A**2) : -0.43080 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.33480 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.130 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.042 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.042 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.040 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.040 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.962 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2158 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2970 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 785 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 45 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 338 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2158 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 274 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2970 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.13 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 5.09 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.18 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 24.6633 1.6790 42.1359 REMARK 3 T TENSOR REMARK 3 T11: -0.0169 T22: -0.0221 REMARK 3 T33: -0.0194 T12: 0.0039 REMARK 3 T13: -0.0039 T23: 0.0048 REMARK 3 L TENSOR REMARK 3 L11: 0.5388 L22: 0.3476 REMARK 3 L33: 0.6634 L12: -0.0827 REMARK 3 L13: -0.2575 L23: 0.2044 REMARK 3 S TENSOR REMARK 3 S11: -0.0210 S12: -0.0366 S13: -0.0175 REMARK 3 S21: 0.0144 S22: 0.0112 S23: -0.0032 REMARK 3 S31: -0.0022 S32: 0.0249 S33: 0.0098 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5UGG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-JAN-17. REMARK 100 THE DEPOSITION ID IS D_1000225828. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-OCT-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95370 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 67976 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.200 REMARK 200 RESOLUTION RANGE LOW (A) : 57.650 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : 13.30 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 33.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.26 REMARK 200 COMPLETENESS FOR SHELL (%) : 83.1 REMARK 200 DATA REDUNDANCY IN SHELL : 7.80 REMARK 200 R MERGE FOR SHELL (I) : 0.42400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 7.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.93 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10 % (W/V) POLYETHYLENE GLYCOL 6,000, REMARK 280 4 % (V/V) 2-METHYL-2,4-PENTANEDIOL, 0.1M (2-(N-MORPHOLINO) REMARK 280 ETHANESULFONIC ACID), PH 5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 19.74000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 541 REMARK 465 PHE A 542 REMARK 465 ALA A 543 REMARK 465 GLY A 560 REMARK 465 ARG A 561 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG A 582 CB CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 621 -54.84 -125.36 REMARK 500 PHE A 692 150.54 78.97 REMARK 500 PHE A 692 155.02 71.68 REMARK 500 PHE A 715 -102.84 -106.33 REMARK 500 LYS A 750 -60.92 68.33 REMARK 500 ASP A 751 12.54 -148.16 REMARK 500 SER A 760 -65.03 -120.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 89M A 801 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5UGD RELATED DB: PDB REMARK 900 5UGD CONTAINS THE SAME PROTEIN COMPLEX WITH YO-2 DBREF 5UGG A 543 791 UNP P00747 PLMN_HUMAN 562 810 SEQADV 5UGG GLU A 541 UNP P00747 EXPRESSION TAG SEQADV 5UGG PHE A 542 UNP P00747 EXPRESSION TAG SEQRES 1 A 251 GLU PHE ALA PRO SER PHE ASP CYS GLY LYS PRO GLN VAL SEQRES 2 A 251 GLU PRO LYS LYS CYS PRO GLY ARG VAL VAL GLY GLY CYS SEQRES 3 A 251 VAL ALA HIS PRO HIS SER TRP PRO TRP GLN VAL SER LEU SEQRES 4 A 251 ARG THR ARG PHE GLY MET HIS PHE CYS GLY GLY THR LEU SEQRES 5 A 251 ILE SER PRO GLU TRP VAL LEU THR ALA ALA HIS CYS LEU SEQRES 6 A 251 GLU LYS SER PRO ARG PRO SER SER TYR LYS VAL ILE LEU SEQRES 7 A 251 GLY ALA HIS GLN GLU VAL ASN LEU GLU PRO HIS VAL GLN SEQRES 8 A 251 GLU ILE GLU VAL SER ARG LEU PHE LEU GLU PRO THR ARG SEQRES 9 A 251 LYS ASP ILE ALA LEU LEU LYS LEU SER SER PRO ALA VAL SEQRES 10 A 251 ILE THR ASP LYS VAL ILE PRO ALA CYS LEU PRO SER PRO SEQRES 11 A 251 ASN TYR VAL VAL ALA ASP ARG THR GLU CYS PHE ILE THR SEQRES 12 A 251 GLY TRP GLY GLU THR GLN GLY THR PHE GLY ALA GLY LEU SEQRES 13 A 251 LEU LYS GLU ALA GLN LEU PRO VAL ILE GLU ASN LYS VAL SEQRES 14 A 251 CYS ASN ARG TYR GLU PHE LEU ASN GLY ARG VAL GLN SER SEQRES 15 A 251 THR GLU LEU CYS ALA GLY HIS LEU ALA GLY GLY THR ASP SEQRES 16 A 251 SER CYS GLN GLY ASP SER GLY GLY PRO LEU VAL CYS PHE SEQRES 17 A 251 GLU LYS ASP LYS TYR ILE LEU GLN GLY VAL THR SER TRP SEQRES 18 A 251 GLY LEU GLY CYS ALA ARG PRO ASN LYS PRO GLY VAL TYR SEQRES 19 A 251 VAL ARG VAL SER ARG PHE VAL THR TRP ILE GLU GLY VAL SEQRES 20 A 251 MET ARG ASN ASN HET 89M A 801 42 HETNAM 89M NALPHA-[TRANS-4-(AMINOMETHYL)CYCLOHEXANE-1-CARBONYL]-N- HETNAM 2 89M OCTYL-O-[(QUINOLIN-2-YL)METHYL]-L-TYROSINAMIDE FORMUL 2 89M C35 H48 N4 O3 FORMUL 3 HOH *289(H2 O) HELIX 1 AA1 ALA A 601 LEU A 605 5 5 HELIX 2 AA2 ARG A 610 SER A 612 5 3 HELIX 3 AA3 GLU A 706 ASN A 711 1 6 HELIX 4 AA4 PHE A 780 ASN A 791 1 12 SHEET 1 AA1 8 CYS A 566 VAL A 567 0 SHEET 2 AA1 8 LYS A 698 ILE A 705 -1 O GLU A 699 N CYS A 566 SHEET 3 AA1 8 GLU A 724 ALA A 727 -1 O CYS A 726 N ILE A 705 SHEET 4 AA1 8 GLY A 772 ARG A 776 -1 O TYR A 774 N LEU A 725 SHEET 5 AA1 8 LYS A 752 TRP A 761 -1 N TRP A 761 O VAL A 773 SHEET 6 AA1 8 PRO A 744 GLU A 749 -1 N GLU A 749 O LYS A 752 SHEET 7 AA1 8 GLU A 679 GLY A 684 -1 N PHE A 681 O VAL A 746 SHEET 8 AA1 8 LYS A 698 ILE A 705 -1 O LEU A 702 N CYS A 680 SHEET 1 AA2 7 GLN A 576 THR A 581 0 SHEET 2 AA2 7 HIS A 586 SER A 594 -1 O CYS A 588 N LEU A 579 SHEET 3 AA2 7 TRP A 597 THR A 600 -1 O LEU A 599 N THR A 591 SHEET 4 AA2 7 ALA A 648 LEU A 652 -1 O ALA A 648 N THR A 600 SHEET 5 AA2 7 GLN A 631 LEU A 640 -1 N SER A 636 O LYS A 651 SHEET 6 AA2 7 TYR A 614 LEU A 618 -1 N LEU A 618 O GLN A 631 SHEET 7 AA2 7 GLN A 576 THR A 581 -1 N ARG A 580 O LYS A 615 SSBOND 1 CYS A 548 CYS A 666 1555 1555 2.05 SSBOND 2 CYS A 558 CYS A 566 1555 1555 2.02 SSBOND 3 CYS A 588 CYS A 604 1555 1555 2.04 SSBOND 4 CYS A 680 CYS A 747 1555 1555 2.03 SSBOND 5 CYS A 710 CYS A 726 1555 1555 2.03 SSBOND 6 CYS A 737 CYS A 765 1555 1555 2.04 SITE 1 AC1 19 GLN A 552 PHE A 587 CYS A 588 HIS A 603 SITE 2 AC1 19 LYS A 607 ASP A 735 SER A 736 CYS A 737 SITE 3 AC1 19 GLN A 738 GLY A 739 ASP A 740 SER A 741 SITE 4 AC1 19 GLY A 764 HOH A 983 HOH A1023 HOH A1038 SITE 5 AC1 19 HOH A1068 HOH A1082 HOH A1107 CRYST1 49.550 39.480 62.130 90.00 111.88 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020182 0.000000 0.008105 0.00000 SCALE2 0.000000 0.025329 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017345 0.00000